Table 1.
Baseline Characteristics of Low Weight Females Never on SSRI, on SSRI Less than 6 Months, and on SSRI Greater than 6 Months
| Baseline Characteristics | Subjects Never on SSRI N=95 |
Subjects on SSRI <6M N=38 |
Subjects on SSRI >6M N=22 |
P value |
|---|---|---|---|---|
| Age (years) | 16.6 ± 1.8a | 17.0 ± 2.3 | 17.9 ± 2.1 | 0.03 |
| Bone age (years) | 15.9 ± 1.4 | 16.2 ± 1.8 | 16.0 ± 1.1 | NS |
| BMI (kg/m2) | 16.98 ± 1.17b | 17.50 ± 1.03 | 17.27 ± 1.69 | 0.05 |
| % Ideal Body Weight | 82.8 ± 5.1 | 84.8 ± 4.1 | 83.2 ± 6.2 | NS |
| Tanner Stage | 4.6 ± 0.7 | 4.5 ± 0.8 | 4.7 ± 0.6 | NS |
| Duration since diagnosis (months) |
13.8 ± 17.1a | 11.1 ± 11.7a | 31.3 ± 31.2 | 0.0003 |
| Duration of amenorrhea (months) |
7.6 ± 8.5 | 8.6 ± 8.8 | 11.6 ± 21.9 | NS |
NS indicates not significant
Mean ± SD
ANOVA followed by the Tukey-Kramer test to adjust for multiple comparisons
a
p <0.05 compared with females on SSRI > 6M
b
p <0.05 compared with females on SSRI <6M